Results 151 to 160 of about 15,380 (223)

Neoadjuvant FOLFIRINOX Chemotherapy Improved Rectal Cancer Outcomes

Oncology Times, 2021
openaire   +2 more sources

Safe Proton Beam Re-irradiation With a Bioabsorbable Spacer in Pancreatic Cancer: A Case Report. [PDF]

Int J Part Ther
Shiba S, Tokuuye K, Koizumi K, Kawahara T, Fujiwara N, Yamaue H, Fujii S, Omura M.   +7 more
europepmc   +1 more source

A serum-derived 3D tumor model platform for personalized prediction and monitoring of chemotherapeutic response in pancreatic ductal adenocarcinoma. [PDF]

Transl Oncol
Cherradi S, Roux S, Dupuy M, Assenat E, Duong HT.   +4 more
europepmc   +1 more source

A Case of Recurrent Acute Pancreatitis After Gemcitabine + Nab-Paclitaxel and Modified FOLFIRINOX Therapy for Advanced Recurrent Pancreatic Cancer. [PDF]

Cureus
Inada Y, Sango H, Kasuga N, Yukawa H, Sano M.   +4 more
europepmc   +1 more source

The role of chemoradiotherapy after induction in locally advanced pancreatic cancer: lessons learnt from CONKO-007. [PDF]

J Gastrointest Oncol
Athanasiou C, Pandanaboyana S.
europepmc   +1 more source

Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A Narrative Review. [PDF]

Ann Surg Oncol
Liguori L, Ventin M, Cattaneo G, Zhang L, Osipov A, Sabbatino F, Ferrone CR.   +6 more
europepmc   +1 more source

Surgery based on resectability status of pancreatic cancer: a narrative review. [PDF]

Jpn J Clin Oncol
Einama T, Ohara M, Ichio K, Kobayashi K, Shinada H, Yonamine N, Tsunenari T, Takao M, Takihata Y, Ueno H, Kishi Y.   +10 more
europepmc   +1 more source

188 A Case of FOLFIRINOX-Induced SiADH

American Journal of Kidney Diseases, 2020
openaire   +1 more source

Single-Cell-Derived Tumor Organoid (STO) arrays on a microfluidic chip for personalized drug screening to address heterogeneity-induced drug resistance in colorectal cancer. [PDF]

Microsyst Nanoeng
Lin D, Luo Y, Chen J, Ma Z, Kang H, Wang X, Wang L, Liu D.   +7 more
europepmc   +1 more source

Second-line nab-paclitaxel and gemcitabine for advanced pancreatic cancer following FOLFIRINOX: outcomes and insights. [PDF]

Am J Cancer Res
Merc Cetınkaya A, Tatlı AM, Goktas Aydın S, Kılıckap S, Bılıcı A, Bırıcık FS, Kostek O, Kayıkcıoglu E, Paydas S, Artac M, Teker F, Cıl T, Kaplan MA, Hacıbekıroglu İ, Geredelı C, Bayram E, Altıntas YE, Celebı AS, Kocak MZ, Arak H, Arslan Benlı B, Arvas H, Dınc Sonusen S, Sezgın Goksu S.   +23 more
europepmc   +1 more source